Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Maternal Broadly Neutralizing Antibodies Can Select for Neutralization-Resistant, Infant-Transmitted/Founder HIV Variants

Journal Article · · mBio (Online)
Each year, >180,000 infants become infected via mother-to-child transmission (MTCT) of HIV despite the availability of effective maternal antiretroviral treatments, underlining the need for a maternal HIV vaccine. We characterized 224 maternal HIV envelope (Env)-specific IgG monoclonal antibodies (MAbs) from seven nontransmitting and transmitting HIV-infected U.S. and Malawian mothers and examined their neutralization activities against nontransmitted autologous circulating viruses and infant-transmitted founder (infant-T/F) viruses. Only a small subset of maternal viruses, 3 of 72 (4%), were weakly neutralized by maternal linear V3 epitope-specific IgG MAbs, whereas 6 out of 6 (100%) infant-T/F viruses were neutralization resistant to these V3-specific IgG MAbs. We also show that maternal-plasma broadly neutralizing antibody (bNAb) responses targeting the V3 glycan supersite in a transmitting woman may have selected for an N332 V3 glycan neutralization-resistant infant-T/F virus. These data have important implications for bNAb-eliciting vaccines and passively administered bNAbs in the setting of MTCT.
Research Organization:
Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
Sponsoring Organization:
USDOE National Nuclear Security Administration (NNSA); National Institutes of Health (NIH)
Grant/Contract Number:
89233218CNA000001
OSTI ID:
1767003
Report Number(s):
LA-UR--21-20585
Journal Information:
mBio (Online), Journal Name: mBio (Online) Journal Issue: 2 Vol. 11; ISSN 2150-7511
Publisher:
American Society for Microbiology (ASM)Copyright Statement
Country of Publication:
United States
Language:
English

References (77)

Duration of Infant Protection Against Influenza Illness Conferred by Maternal Immunization: Secondary Analysis of a Randomized Clinical Trial journal September 2016
Maternal IgG1 and IgA antibody to V3 loop consensus sequence and maternal-infant HIV-1 transmission journal October 1994
Cooperation of B Cell Lineages in Induction of HIV-1-Broadly Neutralizing Antibodies journal July 2014
Fc Characteristics Mediate Selective Placental Transfer of IgG in HIV-Infected Women journal June 2019
A Blueprint for HIV Vaccine Discovery journal October 2012
Strain-Specific V3 and CD4 Binding Site Autologous HIV-1 Neutralizing Antibodies Select Neutralization-Resistant Viruses journal September 2015
HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design journal August 2019
High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies journal June 2009
Last cases of rubella and congenital rubella syndrome in Spain, 1997–2016: The success of a vaccination program journal January 2019
HIV-1 envelope pseudotyped viral vectors and infectious molecular clones expressing the same envelope glycoprotein have a similar neutralization phenotype, but culture in peripheral blood mononuclear cells is associated with decreased neutralization sensitivity journal September 2005
Subtype-specific conservation of isoleucine 309 in the envelope V3 domain is linked to immune evasion in subtype C HIV-1 infection journal August 2010
Cross-neutralizing activity of human anti-V3 monoclonal antibodies derived from non-B clade HIV-1 infected individuals journal May 2013
Pertussis vaccine in pregnancy—first dose for every infant? journal October 2014
Human placental Fc receptors journal July 1994
Restricted isotype, distinct variable gene usage, and high rate of gp120 specificity of HIV-1 envelope-specific B cells in colostrum compared with those in blood of HIV-1-infected, lactating African women journal August 2014
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals journal March 2009
HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption journal June 2016
HIV envelope V3 region mimic embodies key features of a broadly neutralizing antibody lineage epitope journal March 2018
Difficult-to-neutralize global HIV-1 isolates are neutralized by antibodies targeting open envelope conformations journal July 2019
Combination therapy with anti-HIV-1 antibodies maintains viral suppression journal September 2018
The repertoire of maternal anti-viral antibodies in human newborns journal March 2019
Computational analysis of anti-HIV-1 antibody neutralization panel data to identify potential functional epitope residues journal June 2013
Apparent Enhancement of Perinatal Transmission of Human Immunodeficiency Virus Type 1 by High Maternal Anti‐gp160 Antibody Titer
  • Pancino, Gianfranco; Leste‐Lasserre, Thierry; Burgard, Marianne
  • The Journal of Infectious Diseases, Vol. 177, Issue 6 https://doi.org/10.1086/517435
journal June 1998
Influenza Vaccine Given to Pregnant Women Reduces Hospitalization Due to Influenza in Their Infants journal December 2010
SoDA: implementation of a 3D alignment algorithm for inference of antigen receptor recombinations journal December 2005
Mother-to-Child Transmission of Human Immunodeficiency Virus Type 1: Correlation with Neutralizing Antibodies against Primary Isolates journal July 1993
Mother-to-child transmission of HIV-1 in Congo, central Africa journal January 1994
Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection journal January 2014
Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants journal February 1992
Staged induction of HIV-1 glycan–dependent broadly neutralizing antibodies journal March 2017
Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies journal November 2009
Maternal Binding and Neutralizing IgG Responses Targeting the C-Terminal Region of the V3 Loop Are Predictive of Reduced Peripartum HIV-1 Transmission Risk journal February 2017
Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies journal December 2013
Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission. journal January 1995
Selection for Human Immunodeficiency Virus Type 1 Envelope Glycosylation Variants with Shorter V1-V2 Loop Sequences Occurs during Transmission of Certain Genetic Subtypes and May Impact Viral RNA Levels journal May 2005
Neutralization Escape Variants of Human Immunodeficiency Virus Type 1 Are Transmitted from Mother to Infant journal December 2005
Maternal but Not Infant Anti-HIV-1 Neutralizing Antibody Response Associates with Enhanced Transmission and Infant Morbidity journal October 2017
Maternal HIV-1 envelope–specific antibody responses and reduced risk of perinatal transmission journal June 2015
Estimating time since infection in early homogeneous HIV-1 samples using a poisson model journal October 2010
The role of neutralizing antibodies in prevention of HIV-1 infection: what can we learn from the mother-to-child transmission context? journal October 2013
Postnatally-transmitted HIV-1 Envelope variants have similar neutralization-sensitivity and function to that of nontransmitted breast milk variants journal January 2013
Genotypic and functional properties of early infant HIV-1 envelopes journal January 2011
Escape from Autologous Neutralizing Antibodies in Acute/Early Subtype C HIV-1 Infection Requires Multiple Pathways journal September 2009
A Limited Number of Antibody Specificities Mediate Broad and Potent Serum Neutralization in Selected HIV-1 Infected Individuals journal August 2010
Early Low-Titer Neutralizing Antibodies Impede HIV-1 Replication and Select for Virus Escape journal May 2012
Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide text January 2017
Evolution of an HIV glycan–dependent broadly neutralizing antibody epitope through immune escape
  • Tandile, Hermanus,; Abdool, Karim, Quarraisha; E., Lambson, Bronwen
  • The University of North Carolina at Chapel Hill University Libraries https://doi.org/10.17615/e8bk-6082
text January 2012
Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection
  • F., Salazar-Gonzalez, Jesus; P., Busch, Michael; S., Perelson, Alan
  • The University of North Carolina at Chapel Hill University Libraries https://doi.org/10.17615/f6s9-vz03
text January 2008
Maternal and neonatal tetanus elimination: from protecting women and newborns to protecting all journal February 2015
Measuring HIV Neutralization in a Luciferase Reporter Gene Assay book January 2009
Effectiveness of maternal pertussis vaccination in England: an observational study journal October 2014
Sequential Immunization Elicits Broadly Neutralizing Anti-HIV-1 Antibodies in Ig Knockin Mice journal September 2016
Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates journal February 2017
HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design journal January 2019
Vaccine-induced Human Antibodies Specific for the Third Variable Region of HIV-1 gp120 Impose Immune Pressure on Infecting Viruses journal November 2014
Maternal IgG1 and IgA antibody to V3 loop consensus sequence and maternal-infant HIV-1 transmission journal February 1994
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus journal April 2013
Evolution of an HIV glycan–dependent broadly neutralizing antibody epitope through immune escape journal October 2012
Antibody 10-1074 suppresses viremia in HIV-1-infected individuals journal January 2017
Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals journal September 2018
Effectiveness of Maternal Influenza Immunization in Mothers and Infants journal October 2008
Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection journal May 2008
SeaView Version 4: A Multiplatform Graphical User Interface for Sequence Alignment and Phylogenetic Tree Building journal October 2009
Development of broadly neutralizing antibodies from autologous neutralizing antibody responses in HIV infection journal January 2014
Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection journal January 2014
Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide journal March 2017
Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies journal November 2009
Maternal Binding and Neutralizing IgG Responses Targeting the C-Terminal Region of the V3 Loop Are Predictive of Reduced Peripartum HIV-1 Transmission Risk journal February 2017
Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies journal December 2013
Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission. journal January 1995
Selection for Human Immunodeficiency Virus Type 1 Envelope Glycosylation Variants with Shorter V1-V2 Loop Sequences Occurs during Transmission of Certain Genetic Subtypes and May Impact Viral RNA Levels journal May 2005
Neutralization Escape Variants of Human Immunodeficiency Virus Type 1 Are Transmitted from Mother to Infant journal December 2005
Maternal but Not Infant Anti-HIV-1 Neutralizing Antibody Response Associates with Enhanced Transmission and Infant Morbidity journal October 2017
Maternal HIV-1 envelope–specific antibody responses and reduced risk of perinatal transmission journal June 2015
Infant transmitted/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma journal April 2018
Maternal and Infant Factors Predicting Disease Progression in Human Immunodeficiency Virus Type 1-Infected Infants journal January 2000
Maternal and neonatal tetanus elimination: from protecting women and newborns to protecting all journal February 2015